Frédéric Lagarce
Impact in
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 32
- Nanoparticle-Based Drug Delivery 32
-
- Advanced Drug Delivery Systems 15
- Drug Solubulity and Delivery Systems 12
- Co-authors
- Jean‐Pierre Benoît (27 shared papers)Emilie Roger (15 shared papers)Emmanuel Garcion (6 shared papers)Khaled Messaoudi (5 shared papers)Anne Clavreul (8 shared papers)Anne‐Claire Groo (4 shared papers)Fabienne Danhier (5 shared papers)Guillaume Bastiat (5 shared papers)
- Journals
- International Journal of Pharmaceutics (12 papers)Drug Discovery Today (8 papers)International Journal of Nanomedicine (6 papers)European Journal of Pharmaceutics and Biopharmaceutics (4 papers)Journal of Controlled Release (4 papers)
- Partner nations
- FranceBelgiumSwitzerland
In The Last Decade
Frédéric Lagarce
73 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 110
- Pharmaceutical Science 1.2k
- Biomaterials 1.2k
- Drug Discovery 17
- Genetics 334
- Molecular Medicine 157
Countries citing papers authored by Frédéric Lagarce
This map shows the geographic impact of Frédéric Lagarce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Lagarce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Lagarce more than expected).
Fields of papers citing papers by Frédéric Lagarce
This network shows the impact of papers produced by Frédéric Lagarce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Lagarce. The network helps show where Frédéric Lagarce may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Lagarce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 293 | |
| 2 | 2006 | 242 | |
| 3 | 2009 | 232 | |
| 4 | 2015 | 206 | |
| 5 | 2017 | 132 | |
| 6 | 2016 | 116 | |
| 7 | 2011 | 106 | |
| 8 | 2017 | 103 | |
| 9 | 2015 | 95 | |
| 10 | 2009 | 94 | |
| 11 | 2016 | 93 | |
| 12 | 2009 | 87 | |
| 13 | 2014 | 75 | |
| 14 | 2013 | 73 | |
| 15 | 2010 | 64 | |
| 16 | 2010 | 54 | |
| 17 | 2017 | 54 | |
| 18 | 2014 | 49 | |
| 19 | 2017 | 48 | |
| 20 | 2011 | 47 |
About Frédéric Lagarce
Frédéric Lagarce is a scholar working on Biomaterials, Pharmaceutical Science, Analytical Chemistry, Pharmacology and Genetics, having authored 75 papers that have together received 3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (32 papers), Advanced Drug Delivery Systems (15 papers), Drug Solubulity and Delivery Systems (12 papers), Analytical Methods in Pharmaceuticals (12 papers), Pharmacy and Medical Practices (8 papers), Glioma Diagnosis and Treatment (7 papers), RNA Interference and Gene Delivery (4 papers) and Hydrogels: synthesis, properties, applications (3 papers). The work is most often cited by research in Pharmaceutical Science (1.2k citations), Biomaterials (1.2k citations), Drug Discovery (17 citations), Genetics (334 citations) and Molecular Medicine (157 citations). Frédéric Lagarce has collaborated with scholars based in France, Belgium and Switzerland. Frequent co-authors include Jean‐Pierre Benoît, Emilie Roger, Emmanuel Garcion, Khaled Messaoudi, Anne Clavreul, Anne‐Claire Groo, Fabienne Danhier, Guillaume Bastiat, Chiara Bastiancich and Jean-Michel Oger. Their work appears in journals such as International Journal of Pharmaceutics, Drug Discovery Today, International Journal of Nanomedicine, European Journal of Pharmaceutics and Biopharmaceutics and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.